×

Insulin vitamin D conjugates

  • US 9,616,109 B2
  • Filed: 10/21/2015
  • Issued: 04/11/2017
  • Est. Priority Date: 10/22/2014
  • Status: Active Grant
First Claim
Patent Images

1. A carrier-drug conjugate, comprising a targeting group that is a non-hormonal vitamin D not hydroxylated at the carbon 1 position, conjugated to an insulin peptide at the carbon 3 position of said non-hormonal vitamin D targeting group.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×